Physician

Ajith J Kumar, MD

According to 2025 Medicare claims, Ajith Kumar, MD (NPI: 1609952381) practices nephrology in the Lewiston, ID-WA market, with the plurality of this provider's patient population coming from Nez Perce, ID. This provider's primary affiliated billing organization is KIDNEY & HYPERTENSION CLINIC PLLC (NPI: 1174789325; TIN: 26-3120062) and primary practice location at 83501-3502. Kumar is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), MultiCare Connected Care, LLC (ACO ID: A3631), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Kumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 628 traditional Medicare patients, billed 2,056 HCPCS/CPT codes, and received $215,233 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,693 prescription claims across 338 beneficiaries totaling $183,971 in drug costs, led by Jardiance (Empagliflozin). DME data shows 233 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $551,031 to $183,971. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,357 and ending at $3,326.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	471	11,026	$235,808
2016	496	5,813	$226,377
2017	526	7,054	$216,100
2018	546	5,438	$243,148
2019	590	2,186	$233,420
2020	532	2,228	$232,873
2021	523	1,880	$263,415
2022	470	1,345	$180,746
2023	462	1,369	$165,634
2024	628	2,056	$215,233

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	360	4,853	$551,031
2016	359	4,953	$610,029
2017	339	4,285	$589,576
2018	337	4,475	$489,087
2019	351	4,004	$350,624
2020	360	3,873	$305,121
2021	386	3,610	$224,714
2022	358	3,258	$211,806
2023	345	3,203	$271,631
2024	338	2,693	$183,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	324	$21,223
2016	N/R	351	$18,113
2017	N/R	407	$20,505
2018	33	488	$24,120
2019	23	405	$21,371
2020	39	493	$21,763
2021	35	473	$17,718
2022	11	446	$14,819
2023	N/R	341	$11,878
2024	N/R	233	$6,242

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	99	100	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	233	416	$77
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	190	568	$61
99238	Hospital discharge day management, 30 minutes or less	94	94	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	120	135	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	31	1,752	$33,059
Prosol	Parenteral Amino Acid 20% No.1	89	628	$13,244
Lokelma	Sodium Zirconium Cyclosilicate	17	878	$11,253
Farxiga	Dapagliflozin Propanediol	15	392	$7,127
Torsemide	Torsemide	333	20,919	$6,226

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	12	$2,211
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	59	$1,002
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	62	$986
J7500	Azathioprine, oral, 50 mg	N	N/R	12	$960
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	55	$702

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Ajith J. Kumar, MD?

Tedicare shows public-source Medicare data for Ajith J. Kumar, MD (NPI 1609952381), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajith J. Kumar, MD have ACO affiliation data?

Ajith J. Kumar, MD is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), MultiCare Connected Care, LLC (MSSP, ACO ID A3631), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Ajith J. Kumar, MD?

Ajith J. Kumar, MD is linked to KIDNEY & HYPERTENSION CLINIC PLLC (billing NPI 1174789325) in the available physician profile data.

Does Ajith J. Kumar, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.